Home > Healthcare > Hormone Replacement Therapy Market > Table of Contents

Hormone Replacement Therapy Market Size - By Product (Estrogen, Progesterone, Thyroid, Growth Hormone, Testosterone), Route of Administration (Oral, Parenteral), Disease (Menopause, Growth Hormone Deficiency), Distribution Channel, Global Forecast, 2023-2032

  • Report ID: GMI6554
  • Published Date: Aug 2023
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market definition

1.2    Base estimates & calculations

1.3    Forecast calculation

1.4    Covid-19 impact analysis at global level

1.5    Data validation

1.6    Data sources

1.6.1    Secondary

1.6.1.1   Paid sources

1.6.1.2   Public sources

1.6.2    Primary

Chapter 2   Executive Summary

2.1    Hormone replacement therapy industry 360º synopsis, 2018 – 2032 (USD Million)

2.1.1    Business trends

2.1.2    Region trends

2.1.3    Product trends

2.1.4    Route of administration trends

2.1.5    Disease type trends

2.1.6    Distribution channel trends

Chapter 3   Hormone Replacement Therapy Market Insights

3.1    Industry landscape, 2018 – 2032 (USD Million)

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Increasing geriatric population

3.2.1.2   Rising awareness of post-menopausal issues

3.2.1.3   Increasing development of novel drug delivery systems for hormone imbalance issues

3.2.1.4   Rising prevalence of hormonal disorders

3.2.2    Industry pitfalls & challenges

3.2.2.1   High cost associated with hormone replacement therapy

3.2.2.2   Adverse effects of hormone replacement therapy

3.3    Growth potential analysis

3.3.1    By product

3.3.2    By route of administration

3.3.3    By disease type

3.3.4    By distribution channel

3.4    COVID-19 impact analysis

3.5    Regulatory landscape

3.6    Porter’s analysis

3.7    PESTEL analysis

Chapter 4   Competitive Landscape, 2022

4.1    Introduction

4.2    Company matrix analysis, 2022

4.3    Global company market share analysis, 2022

4.4    Competitive positioning matrix, 2022

4.5    Strategic dashboard, 2022

Chapter 5   Hormone Replacement Therapy Market Estimates and Forecast, By Product (USD Million)

5.1    Key trends, by product

5.2    Estrogen & progesterone replacement therapy

5.3    Thyroid replacement therapy

5.4    Growth hormone replacement therapy

5.5    Parathyroid hormone replacement therapy

5.6    Testosterone replacement therapy

Chapter 6   Hormone Replacement Therapy Market Estimates and Forecast, By Route of Administration (USD Million)

6.1    Key trends, by route of administration

6.2    Oral

6.3    Parenteral

6.4    Other routes of administration

Chapter 7   Hormone Replacement Therapy Market Estimates and Forecast, By Disease Type (USD Million)

7.1    Key trends, by disease type

7.2    Menopause

7.3    Growth hormone deficiency

7.4    Male hypogonadism

7.5    Hypothyroidism

7.6    Hypoparathyroidism

7.7    Other disease types

Chapter 8   Hormone Replacement Therapy Market Estimates and Forecast, By Distribution Channel (USD Million)

8.1    Key trends, by distribution channel

8.2    Retail pharmacies

8.3    Hospital pharmacies

8.4    Online pharmacies

Chapter 9   Hormone Replacement Therapy Market Estimates and Forecast, By Region (USD Million)

9.1    Key trends, by region

9.2    North America

9.2.1    U.S.

9.2.2    Canada

9.3    Europe

9.3.1    Germany

9.3.2    UK

9.3.3    France

9.3.4    Spain

9.3.5    Italy

9.3.6    Switzerland

9.3.7    Rest of Europe

9.4    Asia Pacific

9.4.1    China

9.4.2    Japan

9.4.3    India

9.4.4    Australia

9.4.5    South Korea

9.4.6    Rest of Asia Pacific

9.5    Latin America

9.5.1    Brazil

9.5.2    Mexico

9.5.3    Rest of Latin America

9.6    Middle East & Africa

9.6.1    South Africa

9.6.2    Saudi Arabia

9.6.3    Rest of Middle East & Africa

Chapter 10   Company Profiles

10.1    Eli Lilly and Company

10.2    Bayer AG

10.3    Pfizer Inc.

10.4    Viatris, Inc.

10.5    Noven Pharmaceuticals, Inc.

10.6    Merck & Co., Inc.

10.7    Novo Nordisk A/S

10.8    AbbVie, Inc.

10.9    F. Hoffmann-La Roche Ltd.

10.10    ASCEND Therapeutics US, LLC.

10.11    Abbott Laboratories

10.12    Genentech Inc.

10.13    Teva Pharmaceutical Industries Ltd.

10.14    Novartis AG
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 14
  • Tables & Figures: 288
  • Countries covered: 21
  • Pages: 165
 Download Free Sample